Hepatitis delta virus (HDV) infection in the Brazilian Amazon basin and its role in chronic liver disease

Hepatology ◽  
1994 ◽  
Vol 19 (4) ◽  
pp. I63 ◽  
Author(s):  
J Fonseca
PLoS ONE ◽  
2017 ◽  
Vol 12 (3) ◽  
pp. e0174453 ◽  
Author(s):  
Ingrid Couto ◽  
Marilu Victoria ◽  
Valdiléa G. Veloso ◽  
Lorena Rodrigues ◽  
Beatriz Grinsztejn ◽  
...  

1986 ◽  
Vol 39 (8) ◽  
pp. 897-899 ◽  
Author(s):  
D Zauli ◽  
C Crespi ◽  
F B Bianchi ◽  
A Craxi ◽  
E Pisi

1989 ◽  
Vol 9 (1) ◽  
pp. 23-28 ◽  
Author(s):  
J. Saldanha ◽  
F. di Blasi ◽  
C. Blas ◽  
J. Velosa ◽  
F.M. Ramalho ◽  
...  

Author(s):  
Antonio Aceti ◽  
Osman Mohamud Mohamed ◽  
Barbaro S. Paparo ◽  
Osman Mohamed Mohamud ◽  
Giorgio Quaranta ◽  
...  

1991 ◽  
Vol 12 (1) ◽  
pp. 64-69 ◽  
Author(s):  
Paolo Colombo ◽  
Francesco Di Blasi ◽  
Silvio Magrin ◽  
Carmelo Fabiano ◽  
Vito Di Marco ◽  
...  

1993 ◽  
Vol 6 (3) ◽  
pp. 211-229 ◽  
Author(s):  
L B Polish ◽  
M Gallagher ◽  
H A Fields ◽  
S C Hadler

Hepatitis delta virus, discovered in 1977, requires the help of hepatitis B virus to replicate in hepatocytes and is an important cause of acute, fulminant, and chronic liver disease in many regions of the world. Because of the helper function of hepatitis delta virus, infection with it occurs either as a coinfection with hepatitis B or as a superinfection of a carrier of hepatitis B surface antigen. Although the mechanisms of transmission are similar to those of hepatitis B virus, the patterns of transmission of delta virus vary widely around the world. In regions of the world in which hepatitis delta virus infection is not endemic, the disease is confined to groups at high risk of acquiring hepatitis B infection and high-risk hepatitis B carriers. Because of the propensity of this viral infection to cause fulminant as well as chronic liver disease, continued incursion of hepatitis delta virus into areas of the world where persistent hepatitis B infection is endemic will have serious implications. Prevention depends on the widespread use of hepatitis B vaccine. This review focuses on the molecular biology and the clinical and epidemiologic features of this important viral infection.


2006 ◽  
Vol 80 (13) ◽  
pp. 6469-6477 ◽  
Author(s):  
John L. Casey ◽  
Bud C. Tennant ◽  
John L. Gerin

ABSTRACT A woodchuck-derived hepatitis delta virus (HDV) inoculum was created by transfection of a genotype I HDV cDNA clone directly into the liver of a woodchuck that was chronically infected with woodchuck hepatitis virus. All woodchucks receiving this inoculum became positive for HDV RNA in serum, and 67% became chronically infected, similar to the rate of chronic HDV infection in humans. Analysis of HDV sequences obtained at 73 weeks postinfection indicated that changes had occurred at a rate of 0.5% per year; many of these modifications were consistent with editing by host RNA adenosine deaminase. The appearance of sequence changes, which were not evenly distributed on the genome, was correlated with the course of HDV infection. A limited number of modifications occurred in the consensus sequence of the viral genome that altered the sequence of the hepatitis delta antigen (HDAg). All chronically infected animals examined exhibited these changes 73 weeks following infection, but at earlier times, only one of the HDV carriers exhibited consensus sequence substitutions. On the other hand, sequence modifications in animals that eventually recovered from HDV infection were apparent after 27 weeks. The data are consistent with a model in which HDV sequence changes are selected by host immune responses. Chronic HDV infection in woodchucks may result from a delayed and weak immune response that is limited to a small number of epitopes on HDAg.


2007 ◽  
Vol 80 (2) ◽  
pp. 277-282 ◽  
Author(s):  
Timothy J.S. Cross ◽  
Paolo Rizzi ◽  
Mary Horner ◽  
Anita Jolly ◽  
Munther J. Hussain ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document